Abstract
Chikungunya is not a U.S. nationally notifiable disease and tracking travel-associated and locally acquired cases is currently dependent on voluntary reporting via ArboNET. Electronic healthcare reimbursement claims covering a large proportion of visits to providers'' offices may help overcome some of the limitations of ArboNET in documenting timing, occurrence, and spread of Chikungunya in the U.S.